Aging and aging associated diseases are likely to impart staggering health care costs upon the nation. Hence, there is a critical need to better understand biological aging through the characterization of the molecular changes associated with the aging process, so that potential targets for prevention and therapeutics can be more thoroughly explored. Since chronological age is the best predictor of biological age and age-related diseases, this initiative seeks to profile the metabolic differences between young and old populations of wild type C57BL/6 mice and subsequently study the impact of select stressors on the study population. In addition, since p38 signaling plays a major role in enhancing the expression of some senescence-related genes, stress responses will be investigated in p38a-mutant young and old mice. These mouse models will be used to establish a foundation for future research with human samples and subjects. This proposal is an extension of an ongoing project titled """"""""Genomic and metabolomic responses to alcohol-induced liver damage"""""""" (5U01ES016013-02) and as such aims to broaden the scope of the original study. This project combines the unique expertise and experience of Frank J. Gonzalez's laboratory (National Cancer Institute) and Albert J. Fornace's laboratory. This competitive supplement will support studies on the effects of aging on injury responses by alcohol as well as select environmental toxicants. These studies will also contribute to the development of aging-associated biomarkers and the elucidation at the metabolomic level of changes occurring during stress-induced cellular senescence and biological aging.

Public Health Relevance

The objective of the parent grant is to define effects of chronic alcohol consumption on the liver's genomic and metabolic programs, aiming to exploit these omic alterations for use as biomarkers and potential therapeutic intervention of alcohol-induced liver disease. We expand the work scope for insight into metabolic changes, underscoring biological aging processes and correlating effects of environmental and lifestyle metabolomic changes, underscoring biological aging processes and correlating effects of environmental and lifestyle stressors (alcohol) with aging. This contributes to a systems understanding of aging though metabolomics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01ES016013-03S1
Application #
7891953
Study Section
Special Emphasis Panel (ZES1-LWJ-J (U1))
Program Officer
Shaughnessy, Daniel
Project Start
2007-08-15
Project End
2011-09-30
Budget Start
2010-06-01
Budget End
2011-09-30
Support Year
3
Fiscal Year
2010
Total Cost
$230,250
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Moffat, Ivy; Chepelev, Nikolai; Labib, Sarah et al. (2015) Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water. Crit Rev Toxicol 45:1-43
Manna, Soumen K; Thompson, Matthew D; Gonzalez, Frank J (2015) Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model. Adv Exp Med Biol 815:217-38
Li, Heng-Hong; Hyduke, Daniel R; Chen, Renxiang et al. (2015) Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells. Environ Mol Mutagen 56:505-19
Li, Heng-Hong; Tyburski, John B; Wang, Yi-Wen et al. (2014) Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor ? protects against alcoholic liver disease. Alcohol Clin Exp Res 38:1520-31
Li, Heng-Hong; Doiron, Kathryn; Patterson, Andrew D et al. (2013) Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease. J Transl Med 11:266
Goudarzi, Maryam; Koga, Takayuki; Khozoie, Combiz et al. (2013) PPAR?/? modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity. Toxicology 311:87-98
Patterson, Andrew D; Maurhofer, Olivier; Beyoglu, Diren et al. (2011) Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 71:6590-600
Manna, Soumen K; Patterson, Andrew D; Yang, Qian et al. (2011) UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res 10:4120-33
Manna, Soumen K; Patterson, Andrew D; Yang, Qian et al. (2010) Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res 9:4176-88